We use cookies for a better user experience. Read our Privacy Policy

I Agree

Clostridium Vaccine (Animal Health) Market

Clostridium Vaccine (Animal Health) Market (Animal Species - Bovine, Ovine, Caprine, Swine, and Poultry; Distribution Channel - Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute, and Retail Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Clostridium Vaccines Market: Overview

The increasing government initiatives are growing awareness regarding benefits of clostridium vaccine among consumers. Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg. The increased awareness pertaining to zoonotic diseases and the rising incidence rate of clostridium family diseases are boosting the demand for clostridium vaccine globally. In developing countries, distribution of these vaccines are mainly dependent of government intervention. Whereas, in developed nations, the distribution is dependent upon veterinary hospitals and veterinary clinics. To prevent zoonotic diseases and loss of animals, governments, veterinary hospitals, and veterinary clinics are persistently commencing awareness programs.

It is estimated that the global clostridium vaccine (animal health) market will expand with a steady CAGR of 4.9% throughout the period 2016-2024. Growing with this rate, the market is most likely to reach the value of $643.5 mn by the end of 2024, from its initial value of US$418.0 mn in 2015.

clostridium vaccine market

Large Demand of Pork to Boost the Growth of Swine Segment

The global market for clostridium vaccine can be segmented on the basis of animal species into poultry, swine, caprine, ovine, and bovine. Among these, the swine segment is expected to provide most attractive opportunities for the market growth owing to large demand of pork. Furthermore, the segment is expected to expand with a significant pace due to high possibility of swine getting diagnosed with zoonotic diseases.

However, over the forecast period, the ovine segment is anticipated to project the fastest rate of growth. The increasing prevalence of diseases such as black quarter, black diseases, and blackleg are propelling growth of this sector. Furthermore, government regulations in various geographies, growing awareness among owners, and the massive increase in the world's ovine population are envisioned to surge the demand for this segment over the forecast period.

On the basis of distribution Channel, the market for clostridium vaccine can be bifurcated into retail pharmacy, veterinary research institute, veterinary hospital, and veterinary clinic. Among these, due to technological advancements and development of overall retail industry, retail pharmacy segment is foreseen to expand with an uninterrupted growth rate. In Asia Pacific, the veterinary clinic segment holds a dominant position in the market owing to augmenting government awareness pertained to clostridium diseases and their prevention, across several countries over the region.

Asia Pacific to Project Most Impressive Growth Rate Owing to Rising Prevalence of Clostridial Diseases

On the basis of geography, the clostridium vaccine (animal health) market can be divided into five key regions, namely Middle East and Africa, Latin America, Asia Pacific, Europe, and North America. OF these, the North America segment is expected to grow with a noteworthy rate due to increasing awareness among customers. The increasing demand for meat products and the decreasing arable land are other factors leading to the growth of the market within this region. The developing region, Asia Pacific is also foreseen to provide lucrative growth opportunities owing to the increased government initiatives. The increasing population of countries such as China and India are demanding for meat products. Furthermore, the rising prevalence of clostridial diseases over these countries are most likely to generate high demand for clostridium vaccines, further assisting the expansion of the global market.

Some of the prominent players operating within this market include Bayer AG, Ceva Sante Animale, Bimeda, Inc., Vibrac Corporation,  Eli Lilly and Company, Boehringer Ingelheim,  Sanofi-Aventis (Merial Animal Health), Merck Animal Health, and Zoetis, Inc.

Clostridium Vaccine (Animal Health) Market to Gain Impetus from Rising Cases of Zoonotic Diseases

Expansion in the utilization of meat and other creature inferred items has prompted an increment in pervasiveness of creature determined infections. Also, there is an ascent in speculation on domesticated animals creatures, particularly in the arising economies. These variables have affected the clostridium vaccines market well, subsequently advancing development. One more factor driving the market's development is expanding extra cash around the world.

Moreover, rising mindfulness in regards to zoonotic illnesses and the advantages of clostridium vaccines have added to the market's development. Moreover, governments are taking activities to energize the reception of clostridium vaccines. They are likewise endeavoring to fortify the conveyance organization of the vaccines, in this manner spiking clostridium vaccines market's development.

There is an ascent in the clostridium based contamination passings overall on account of treatment opposition. This is one of the conspicuous elements advancing the development of the worldwide clostridium vaccines market. Moreover, headways in the retail drug store fragment and expansion in the quantity of veterinary centers have braced the market's development.

On the drawback, there are not many controlling components that may cause a defeat in the worldwide clostridium vaccines market. Factors, for example, significant expense of medicines and the worries related with the symptoms of the vaccines may block the market's development. Regardless, expansion in government subsidizing and improvement of new items may introduce worthwhile freedoms for the market's development.

The expanding government activities are developing mindfulness with respect to advantages of clostridium vaccine among purchasers. Clostridium vaccines are utilized to give invulnerability against to an assortment of ovine and ox-like clostridial sicknesses like lockjaw, dark illness, thick kidney (enterotoxaemia), and blackleg. The expanded mindfulness relating to zoonotic illnesses and the increasing frequency pace of clostridium family sicknesses are boosting the interest for clostridium vaccine universally. In non-industrial nations, circulation of these vaccines are chiefly needy of government intercession. To forestall zoonotic infections and loss of creatures, governments, veterinary medical clinics, and veterinary facilities are determinedly starting mindfulness programs.

Clostridium Vaccine (Animal Health) Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section-2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Clostridium Vaccine (Animal Health) Market: Market Snapshot
3.2 Global Clostridium Vaccine (Animal Health) Market: Opportunity Map

Section-4 Market Overview
4.1 Global Clostridium Vaccine (Animal Health) Market: Product Overview
4.2 Global Clostridium Vaccine (Animal Health) Market: Key Industry Developments
4.3 Regulatory Scenario

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
      5.1.2 Drivers
              5.1.2.1 Growing incidence of clostridium family 
              5.1.2.2 Increase in disposable income
              5.1.2.3 Increase in interventions by government bodies
              5.1.2.4 Rise in demand for cattle milk, meat and eggs
              5.1.2.5 Spending on livestock animals to grow globally
              5.1.2.6 Population growth and improved standard of living
              5.1.2.7 Growing awareness among people
              5.1.2.8 Increase in R&D expense as key strategy
      5.1.3 Restraints
              5.1.3.1 High treatment Cost
              5.1.3.2 High dependence on government distribution channel
              5.1.3.3 Stringent Regulations
      5.1.4 Opportunity
              5.1.4.1 Technological Development and Innovation
              5.1.4.2 Significant Scope in Emerging Markets
5.2 Opportunity Analysis
5.3 Key Trends
5.4 Global Clostridium Vaccine (Animal Health) Market Revenue and Volume Projection
5.5 Porter’s Five Forces Analysis
5.6 Clostridium Vaccine (Animal Health) Market Outlook

Section-6 Clostridium Vaccine (Animal Health) Market Analysis, by Animal Species
6.1 Key Findings
6.2 Introduction
6.3 Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
6.4 Clostridium Vaccine (Animal Health) Market Forecast, by Animal Species
      6.4.1 Bovine
      6.4.2 Ovine
      6.4.3 Caprine
      6.4.4 Swine
      6.4.5 Poultry
      6.4.6 Others
6.5 Clostridium Vaccine (Animal Health) Market Attractiveness Analysis

Section-7 Clostridium Vaccine (Animal Health) Market Analysis, by Distribution Channel
7.1 Key Findings
7.2 Introduction
7.3 Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
7.4 Clostridium Vaccine (Animal Health) Market Forecast, by Distribution Channel
      7.4.1 Veterinary Clinic
      7.4.2 Veterinary Hospital
      7.4.3 Veterinary Research Institute
      7.4.4 Retail Pharmacy
7.5 Clostridium Vaccine (Animal Health) Market Attractiveness Analysis

Section-8 Clostridium Vaccine (Animal Health) Market Analysis, by Region
8.1 Geographical Scenario
8.2 Introduction
8.3 Clostridium Vaccine (Animal Health) Market Value Share Analysis
8.4 Clostridium Vaccine (Animal Health) Market Forecast
8.5 Clostridium Vaccine (Animal Health) Market Attractiveness Analysis

Section-9 North America Clostridium Vaccine (Animal Health) Market Analysis
9.1 North America Clostridium Vaccine (Animal Health) Market Overview
9.2 North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
9.3 North America Clostridium Vaccine (Animal Health) Market Forecast
9.4 North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
9.5 North America Clostridium Vaccine (Animal Health) Market Forecast
9.6 North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
9.7 North America Clostridium Vaccine (Animal Health) Market Forecast, by Country
9.8 North America Market Attractiveness Analysis

Section-10 Europe Clostridium Vaccine (Animal Health) Market Analysis
10.1 Europe Clostridium Vaccine (Animal Health) Market Overview
10.2 Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
10.3 Europe Clostridium Vaccine (Animal Health) Market Forecast
10.4 Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
10.5 Europe Clostridium Vaccine (Animal Health) Market Forecast
10.6 Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
10.7 Europe Clostridium Vaccine (Animal Health) Market Forecast, by Country
10.8 Europe Market Attractiveness Analysis

Section-11 Asia Pacific Clostridium Vaccine (Animal Health) Market Analysis
11.1 Asia Pacific Clostridium Vaccine (Animal Health) Market Overview
11.2 Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
11.3 Asia Pacific Clostridium Vaccine (Animal Health) Market Forecast
11.4 Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
11.5 Asia Pacific Clostridium Vaccine (Animal Health) Market Forecast
11.6 Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
11.7 Asia Pacific Clostridium Vaccine (Animal Health) Market Forecast, by Country
11.8 Asia Pacific Market Attractiveness Analysis

Section-12 Latin America Clostridium Vaccine (Animal Health) Market Analysis
12.1 Latin America Clostridium Vaccine (Animal Health) Market Overview
12.2 Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
12.3 Latin America Clostridium Vaccine (Animal Health) Market Forecast
12.4 Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
12.5 Latin America Clostridium Vaccine (Animal Health) Market Forecast
12.6 Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
12.7 Latin America Clostridium Vaccine (Animal Health) Market Forecast, by Country
12.8 Latin America Market Attractiveness Analysis

Section-13 Middle East & Africa Clostridium Vaccine (Animal Health) Market Analysis
13.1 Middle East & Africa Clostridium Vaccine (Animal Health) Market Overview
13.2 Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
13.3 Middle East & Africa Clostridium Vaccine (Animal Health) Market Forecast
13.4 Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
13.5 Middle East & Africa Clostridium Vaccine (Animal Health) Market Forecast
13.6 Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
13.7 Middle East & Africa Clostridium Vaccine (Animal Health) Market Forecast, by Country
13.8 Middle East & Africa Market Attractiveness Analysis

Section-14 Competition Landscape 
14.1 Clostridium Vaccine (Animal Health) Market Share Analysis By Company (2015)
14.2 Competition Matrix
14.3 Company Profiles
      14.3.1 Bayer AG 
              14.3.1.1. Company Overview
              14.3.1.2. Business Overview
              14.3.1.3. Financial Overview
              14.3.1.4. SWOT Analysis
              14.3.1.5. Strategic Overview
      14.3.2 Bimeda, Inc. 
              14.3.2.1. Company Overview
              14.3.2.2. Business Overview
              14.3.2.3. Financial Overview
              14.3.2.4. SWOT Analysis
              14.3.2.5. Strategic Overview
      14.3.3 Boehringer Ingelheim GmbH 
              14.3.3.1. Company Overview
              14.3.3.2. Business Overview
              14.3.3.3. Financial Overview
              14.3.3.4. SWOT Analysis
              14.3.3.5. Strategic Overview
      14.3.4 Ceva Sante Animale 
              14.3.4.1. Company Overview
              14.3.4.2. Business Overview
              14.3.4.3. Financial Overview
              14.3.4.4. SWOT Analysis
              14.3.4.5. Strategic Overview
      14.3.5 Eli Lilly and Company (Elanco Animal Health) 
              14.3.5.1. Company Overview
              14.3.5.2. Business Overview
              14.3.5.3. Financial Overview
              14.3.5.4. SWOT Analysis
              14.3.5.5. Strategic Overview
      14.3.6 Merck Animal Health 
              14.3.6.1. Company Overview
              14.3.6.2. Business Overview
              14.3.6.3. Financial Overview
              14.3.6.4. SWOT Analysis
              14.3.6.5. Strategic Overview
      14.3.7 Sanofi S.A. (Merial Animal Health) 
              14.3.7.1. Company Overview
              14.3.7.2. Business Overview
              14.3.7.3. Financial Overview
              14.3.7.4. SWOT Analysis
              14.3.7.5. Strategic Overview
      14.3.8 Virbac
              14.3.8.1. Company Overview
              14.3.8.2. Business Overview
              14.3.8.3. Financial Overview
              14.3.8.4. SWOT Analysis
              14.3.8.5. Strategic Overview
      14.3.9 Zoetis, Inc.
              14.3.9.1. Company Overview
              14.3.9.2. Business Overview
              14.3.9.3. Financial Overview
              14.3.9.4. SWOT Analysis
              14.3.9.5. Strategic Overview

List of Tables

Table 1: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species, 2014–2024
Table 2: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Distribution Channel
Table 3: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 4: North America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species
Table 5: North America Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 6: North America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 7: Europe Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species, 2014–2024
Table 8: Europe Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 9: Europe Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 10: Asia Pacific Clostridium Vaccine (Animal) Market Size (US$ Mn) Forecast, by Animal Species, 2014–2024
Table 11: Asia Pacific Clostridium Vaccine (Animal health) Forecast, by Distribution Channel, 2014–2024
Table 12: Asia Pacific Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Latin America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species,
Table 14: Latin America Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 15: Latin America Clostridium Vaccine Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 16: Middle East & Africa Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, by Animal Species
Table 17: Middle East & Africa Clostridium Vaccine (Animal Health) Forecast, by Distribution Channel, 2014–2024
Table 18: Middle East & Africa Clostridium Vaccine Market Size (US$ Mn) Forecast, by Country, 2014–2024

List of Figures

Figure 1: Global Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Type, 2016 and 2024
Figure 3: Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Animal Species
Figure 4: Global Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 5: Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Distribution Channel
Figure 6: Global Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Region, 2016 and 2024
Figure 7: Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Region
Figure 8: North America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 9: North America Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 10: North America Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 11: North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 12: North America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 13: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 14: North America Market Attractiveness Analysis, by Animal Species 
Figure 15: North America Market Attractiveness Analysis, by Distribution Channel
Figure 16: Europe Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 17: Europe Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 18: Europe Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 19: Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species, 2016 & 2024
Figure 20: Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 21: Europe Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country, 2016 and 2024
Figure 22: Europe Market Attractiveness Analysis, by Animal Species 
Figure 23: Europe Market Attractiveness Analysis, by Distribution Channel
Figure 24: Asia Pacific Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 25: Asia Pacific Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 26: Asia Pacific Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 27: Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 28: Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 29: Asia Pacific Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country, 2016 & 2024
Figure 30: Asia Pacific Market Attractiveness Analysis, by Animal Species 
Figure 31: Asia Pacific Market Attractiveness Analysis, by Distribution Channel
Figure 32: Latin America Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 33: Latin America Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 34: Latin America Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 35: Latin America Clostridium vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 36: Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 37: Latin America Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country, 2016 & 2024
Figure 38: Latin America Market Attractiveness Analysis, by Animal Species 
Figure 39: Latin America Market Attractiveness Analysis, by Distribution Channel
Figure 40: Middle East & Africa Clostridium Vaccine (Animal Health) Market Size (US$ Mn) Forecast, 2016–2024
Figure 41: Middle East & Africa Clostridium Vaccine (Animal Health) Market Size and Volume Y-o-Y Growth Projections
Figure 42: Middle East & Africa Clostridium Vaccine (Animal Health) Market Attractiveness Analysis, by Country
Figure 43: Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Animal Species
Figure 44: Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Distribution Channel
Figure 45: Middle East & Africa Clostridium Vaccine (Animal Health) Market Value Share Analysis, by Country
Figure 46: Middle East & Africa Market Attractiveness Analysis, by Animal Species 
Figure 47: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
Figure 48: Global Clostridium Vaccine (Animal Health) Market Share Analysis By Company (2015)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

139

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved